johnson fistel.jpg
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityBio: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
15. Mai 2024 13:55 ET | Johnson Fistel, LLP
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of...
shareholders foundation logo.jpg
Investors in BioXcel Therapeutics, Inc. (NASDAQ: BTAI) should contact the Shareholders Foundation in connection with a Lawsuit
10. Oktober 2023 09:45 ET | Shareholders Foundation, Inc.
Investors, who lost money with shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI), should contact the Shareholders Foundation, Inc.
johnson fistel.jpg
Investigation Alert BAX, DHR, BTAI, and IBRX: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
26. September 2023 12:27 ET | Johnson Fistel, LLP
SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Baxter International, Inc. (NYSE: BAX) Johnson Fistel, LLP is investigating potential claims on behalf of Baxter International, Inc. (NYSE: BAX). If...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for BTAI, MNK, and STX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
05. September 2023 11:06 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
July 30, 2021 - ROSEN LOGO.jpg
BTAI DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important September 5 Deadline in Securities Class Action – BTAI
01. September 2023 22:08 ET | The Rosen Law Firm PA
NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December...
BL-new-logo.jpg
BIOXCEL THERAPEUTICS, INC. (NASDAQ: BTAI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.
29. August 2023 01:45 ET | Bernstein Liebhard LLP
NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI)?Did you purchase your shares between December 15,...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for IBRX, BTAI, MNK, and STX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
28. August 2023 11:13 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important September 5 Deadline in Securities Class Action – BTAI
26. August 2023 14:03 ET | The Rosen Law Firm PA
NEW YORK, Aug. 26, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December 15,...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for IBRX, BTAI, MNK, and STX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
22. August 2023 11:11 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
BL-new-logo.jpg
BIOXCEL THERAPEUTICS, INC. (NASDAQ: BTAI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.
22. August 2023 07:00 ET | Bernstein Liebhard LLP
NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Do you, or did you, own shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI)? Did you purchase your shares between December 15, 2021 and June 28,...